Aaron Cowen’s ESSA Pharma EPIX Stock Holding History

Aaron Cowen’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-298,800	Closed	-$3.56M	–	116
2020 Q4	$3.56M	Hold	298,800	–	–	0.05%	84
2020 Q3	$2.06M	Buy	+298,800	New	+$2.03M	0.04%	79

Other funds holding EPIX

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Aaron Cowen's EPIX Position: Q1 2021 in Review

Aaron Cowen sold out of ESSA Pharma (EPIX) in Q1 2021, closing a stake of 298,800 shares — an estimated $3.56M sold.

Aaron Cowen first reported a position in EPIX in Q3 2020 and held it in 2 quarters. The position peaked at $3.56M in Q4 2020. 70 funds tracked by Wall St. Rank hold EPIX as of Q1 2021.

Aaron Cowen reported no remaining ESSA Pharma position as of Q1 2021 after selling out during the quarter.
Aaron Cowen sold 298,800 ESSA Pharma shares in Q1 2021, an estimated $3.56M.
Aaron Cowen first reported a position in ESSA Pharma in Q3 2020 and held it in 2 quarters.
Aaron Cowen's ESSA Pharma position peaked at $3.56M in Q4 2020.
70 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2021.

Based on Suvretta Capital Management's 13F filing for Q1 2021, filed 17 May 2021.